Action BRTX BIORESTORATIVE THERAPIES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues BioRestorative Therapies, Inc.

Actions

BRTX

US0906556065

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 27/06/2024 		Varia. 5j. Varia. 1 janv.
1,83 USD -9,41% Graphique intraday de BioRestorative Therapies, Inc. -12,44% +5,18%
27/06 BioRestorative Therapies, Inc. annonce un avis d'acceptation pour un brevet couvrant un aspect fondamental du programme ThermoStem® sur les maladies métaboliques CI
13/06 Les plus fortes hausses de la mi-journée MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
BioRestorative Therapies, Inc. Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(1), Reports First Quarter 2024 Financial Results
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
Top Midday Gainers
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Sector Update: Health Care
BioRestorative Therapies in Licensing Talks for Metabolic Disease Program -- Shares Rise Pre-Bell
Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Thursday Ahead of Key Economic Data
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
BioRestorative Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K
BioRestorative Announces Signing a Five-Year Exclusive Supply Agreement with Cartessa Aesthetics, LLC
BioRestorative Therapies Provides First Quarter 2024 Business Update
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
BioRestorative Therapies, Inc. Enhances Preclinical Metabolic Program with A Novel Exosome-Based Biologic Targeting Obesity
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BRTX
  4. Actualités BioRestorative Therapies, Inc.
  5. Autres langues